Track the Dechra Pharmaceuticals PLC stock price and the full insider trade history of the company, a publicly traded company based in United Kingdom. Shares are listed on UK GB, under the authority of RNS (LSE). The latest transaction was reported on 15 January 2024 (Purchase). Among the most active insiders: Paul Sandland. The full history is free.
16
Insider Decl.
0
Thresholds
€56,133
13 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Buys €56,133· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Dechra Pharmaceuticals PLC is a pharmaceutical company focused on the development and marketing of products for pets and livestock. It is listed on the London Stock Exchange under the ticker XLON.